Author

Omar Delgado

Novartis (Switzerland)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Chia Ling HuangiD· 1 shared Christopher W. WilsoniD· 1 shared Cynthia L. GrosskreutziD· 1 shared Ganesh PrasannaiD· 1 shared Garrett Klokman· 1 shared John T. Demirs· 1 shared Jorge ArandaiD· 1 shared Junzheng YangiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Chia Ling HuangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identification of cellular and molecular risk signatures for progression to late-stage age-related macular degeneration using the 9-step Minnesota Grading System

Chia Ling Huang, Yubin Qiu, John T. Demirs, Xiaoqiu Wu, Michael Twarog, Omar Delgado, Maura A. Crowley, Natasha M. Buchanan, Nhi Vo, Lin Fan, Yanqun Wang, Junzheng Yang, Thomas R. Vollmer, Garrett Klokman, Sandra Jose, , Sha-Mei Liao

This study uses bulk RNA sequencing on postmortem human eye tissue to identify gene and pathway changes associated with progression from intermediate to late-stage AMD, highlighting potential therapeutic targets.

bioRxiv · Jul 10, 2025 · PreprintNeuroscience